Corpus ID: 42301577

Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.

@article{Lejoyeux1996UseOS,
  title={Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.},
  author={M. Lejoyeux},
  journal={Alcohol and alcoholism},
  year={1996},
  volume={31 Suppl 1},
  pages={
          69-75
        }
}
  • M. Lejoyeux
  • Published 1996
  • Medicine
  • Alcohol and alcoholism
Animal studies have shown that alcohol consumption is reduced when serotonin (5-hydroxytryptamine, 5-HT) levels are increased in the central nervous system. Similarly, studies of alcohol-dependent human subjects have shown that treatment with 5-HT reuptake inhibitors (i.e. zimeldine, citalopram, fluoxetine, and fluvoxamine) decreases the desire to drink alcohol and improves symptoms of alcohol-related anxiety and depression in patients who have undergone detoxification. However, not all studies… Expand
Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior
The role of serotonin in craving: from basic research to human studies.
Benzodiazepine treatment for alcohol-dependent patients.
Effect of the combined administration of ethanol and acamprosate on rabbit EEG.
Confirmation and Fine Mapping of Ethanol Sensitivity Quantitative Trait Loci, and Candidate Gene Testing in the LXS Recombinant Inbred Mice